# SSM Predicts Outcomes of CLD Inpatients With Acute Liver Injury

> **NCT06173947** · — · RECRUITING · sponsor: **Nanfang Hospital, Southern Medical University** · enrollment: 411 (estimated)

## Conditions studied

- End Stage Liver Disease
- Jaundice
- Liver Dysfunction
- Portal Hypertension

## Interventions

- **DEVICE:** FibroScan® Expert 630

## Key facts

- **NCT ID:** NCT06173947
- **Lead sponsor:** Nanfang Hospital, Southern Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-01
- **Primary completion:** 2025-09-30
- **Final completion:** 2025-12-30
- **Target enrollment:** 411 (ESTIMATED)
- **Last updated:** 2025-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06173947

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06173947, "SSM Predicts Outcomes of CLD Inpatients With Acute Liver Injury". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT06173947. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*